Italian Pharma, Chiesi Buys Asthma Company Putting It Against Novartis
Felicia Rodriguez
November 23, 2016
A privately owned Italian pharmacy called Chiesi Farmaceutici bought all outstanding shares and assets from the asthma-focused biotech, Atopix Therapeutics. This deal puts Chiesi against an established eosinophilic asthma market. A market which includes targeted biologics such as GlaxoSmithKline’s Nucala and Teva’s Cinqair/Cinqaero, both who